Albemarle Q4 net sales beat estimates

Albemarle

11/02/2026 21:23

Overview

Chemical company's Q4 net sales rose 16%, beating analyst expectations

Adjusted loss per share for Q4 missed analyst expectations

Adjusted EBITDA for Q4 increased 7%, beating analyst estimates

Outlook

Albemarle projects 2026 capital expenditures to be approximately flat year-over-year

Company anticipates meaningful free cash flow generation with higher lithium prices

Albemarle expects to close Ketjen stake sale in Q1 2026

Result Drivers

ENERGY STORAGE GROWTH - Energy Storage segment net sales rose 23% due to higher volumes and pricing

KETJEN SALES INCREASE - Ketjen segment net sales increased 14% driven by higher FCC volumes and favorable product mix

COST AND PRODUCTIVITY IMPROVEMENTS - Achieved $450 mln in cost and productivity improvements, exceeding initial targets

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Net sales
Beat
$1.43 bln
$1.35 bln (16 Analysts)
Q4 Adjusted EPS
Miss
-$0.53
-$0.41 (18 Analysts)
Q4 EPS
-$3.87
Q4 Adjusted EBITDA
Beat
$268.70 mln
$239.47 mln (17 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 11 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the specialty chemicals peer group is "buy"

Wall Street's median 12-month price target for Albemarle Corp is $185.00, about 9.8% above its February 10 closing price of $168.56

Press Release: ID:nPn30DJKJa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)